Who Owns Q32 Bio Stock?
NASDAQ: QTTBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 112.19%
- Institutions (% of float)
- 114.55%
- Held by insiders
- 2.07%
- Institutional holders
- 125
- Institutions 97.9%
- Insiders 2.1%
- Public and other 0.0%
Who owns Q32 Bio stock?
Institutional investors own about 112.2% of Q32 Bio's shares, spread across 125 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.07% of QTTB.
The largest institutional holders are Orbimed Advisors LLC. (13.79%), Atlas Venture Life Science Advisors, LLC (9.08%) and Boxer Capital Management, LLC (8.61%). Together, the top 10 institutions control 70.2% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their QTTB positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of QTTB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Orbimed Advisors LLC. | 4.13M | 13.79% | 0.0% |
| Atlas Venture Life Science Advisors, LLC | 2.72M | 9.08% | 0.0% |
| Boxer Capital Management, LLC | 2.58M | 8.61% | -18.1% |
| BVF Inc. | 2.35M | 7.85% | 0.0% |
| RA Capital Management, L.P. | 2.33M | 7.79% | 0.0% |
| Bank of America Corporation | 2.20M | 7.37% | +100.0% |
| Price (T.Rowe) Associates Inc | 1.50M | 5.02% | +100.0% |
| Opaleye Management Inc. | 1.12M | 3.74% | +20.3% |
| JPMORGAN CHASE & CO | 1.06M | 3.55% | +100.0% |
| Vanguard Capital Management LLC | 1.01M | 3.37% | +94.4% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of QTTB
| Fund | Shares | % Held |
|---|---|---|
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 529.59K | 1.77% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 389.12K | 1.30% |
| Columbia Funds Series Trust I-Columbia Small Cap Growth Fund | 345.93K | 1.16% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 119.27K | 0.40% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 95.68K | 0.32% |
| First TRT Exch-Trd Fd.-First TRT Dow Jones Select MicroCap Index Fd. | 89.13K | 0.30% |
| Columbia Fd.s Series TRT I-Multi-Manager Small Cap Eqy. Strategies Fd. | 66.42K | 0.22% |
| American Century ETF Trust-Avantis U.S. Small Cap Value Fund | 50.63K | 0.17% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 41.05K | 0.14% |
| Bridgeway Funds, Inc.-Ultra-Small Company Fund | 34.61K | 0.12% |
Frequently asked questions
Who is the largest shareholder of Q32 Bio?
Orbimed Advisors LLC. is the largest institutional shareholder of QTTB, owning 13.79% of shares outstanding (4.13M shares) as of its latest 13F filing.
What percentage of Q32 Bio is owned by institutions?
Institutions own about 112.2% of QTTB shares and 114.6% of the public float.
How much of Q32 Bio do insiders own?
Insiders, such as officers and directors, own about 2.07% of QTTB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.